日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice

美国2型糖尿病患者在随机对照试验和临床实践中,使用基础胰岛素治疗后,糖化血红蛋白(A1C)达标率均低于7.0%(<53 mmol/mol)。

Blonde, Lawrence; Brunton, Stephen A; Chava, Pavan; Zhou, Rong; Meyers, Juliana; Davis, Keith L; Dalal, Mehul R; DiGenio, Andres

Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus

传统和基于风险的血糖变异性指标对2型糖尿病降糖治疗效果的敏感性

Kovatchev, Boris; Umpierrez, Guillermo; DiGenio, Andres; Zhou, Rong; Inzucchi, Silvio E

Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis

比较甘精胰岛素和噻唑烷二酮类药物对2型糖尿病患者血浆脂质的影响:一项基于患者水平的汇总分析

Chaudhuri, Ajay; Rosenstock, Julio; DiGenio, Andres; Meneghini, Luigi; Hollander, Priscilla; McGill, Janet B; Dandona, Paresh; Ilgenfritz, John; Riddle, Matthew

Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion

胆固醇酯转移蛋白抑制对高密度脂蛋白亚型、载脂蛋白AI代谢和粪便甾醇排泄的影响

Brousseau, Margaret E; Diffenderfer, Margaret R; Millar, John S; Nartsupha, Chorthip; Asztalos, Bela F; Welty, Francine K; Wolfe, Megan L; Rudling, Mats; Björkhem, Ingemar; Angelin, Bo; Mancuso, James P; Digenio, Andres G; Rader, Daniel J; Schaefer, Ernst J